# Efficacy and Safety of Superior Vena Cava Isolation and Pulmonary Vein Isolation for Treatment of Atrial Fibrillation

> **NCT07724899** · NA · RECRUITING · sponsor: **Qiang Hu** · enrollment: 200 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)

## Interventions

- **PROCEDURE:** superior vena cava isolation plus pulmonary Vein isolation
- **PROCEDURE:** pulmonary vein isolation

## Key facts

- **NCT ID:** NCT07724899
- **Lead sponsor:** Qiang Hu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-20
- **Primary completion:** 2029-03-31
- **Final completion:** 2029-03-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07724899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07724899, "Efficacy and Safety of Superior Vena Cava Isolation and Pulmonary Vein Isolation for Treatment of Atrial Fibrillation". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07724899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*